tiprankstipranks
Trending News
More News >
Unicharm Corporation (JP:8113)
:8113
Advertisement

Unicharm (8113) AI Stock Analysis

Compare
7 Followers

Top Page

JP:8113

Unicharm

(OTC:8113)

Rating:65Neutral
Price Target:
¥1,208.00
▲(17.97% Upside)
Unicharm's overall score is driven by its strong financial performance, indicating a stable and resilient company. However, bearish technical indicators suggest potential downside risk, while valuation metrics show moderate attractiveness. The absence of notable earnings call data or corporate events means these areas do not impact the score.

Unicharm (8113) vs. iShares MSCI Japan ETF (EWJ)

Unicharm Business Overview & Revenue Model

Company DescriptionUnicharm Corporation engages in the manufacture and sale of baby and childcare, feminine care, health care, cosmetic, household, and pet care products in Japan and internationally. Its baby and child care products, including disposable diapers and baby wipes under the Moony, MamyPoko, Oyasumiman, and Torepanman brands; and feminine care products comprise napkins, tampons, panty liners, sanitary short, and other feminine care products under the Sofy, Center-In, and Unicharm brands. The company's wellness care products include napkin-type incontinence pads, pants-type diapers, tape-type diapers, pants-type specialized urine pads, and tape-type specialized urine pads under the Lifree and Charmnap brand; and masks under the Unicharm brands. It also provides home care products, including cleaning sheets under the Wave brand; cosmetic cotton and wet wipes under the Silcot brand; and paper towels under the Cook Up brand. In addition, the company offers pet care products that include pet foods, excrement cleanup sheets, system toilets, and disposable diapers under the Grand Deli, Best Balance, Physicalife Dog, Silver Plate, Manner Wear, Deo Sheet, Silver Spoon, AllWell, Physicalife Cat, Deo Toilet, Deo Sand, Deo Clean, Aiken Genki, and Neko Genki brands. Further, it is involved in the manufacture and sale of industrial materials, food-packaging materials, etc. The company was incorporated in 1941 and is headquartered in Tokyo, Japan.
How the Company Makes MoneyUnicharm generates revenue primarily through the sale of its diverse product lines, which are distributed through various retail channels, including supermarkets, drugstores, and online platforms. The company's key revenue streams are its baby care and feminine care segments, which contribute significantly to its earnings. Unicharm's global presence allows it to capitalize on growing markets in Asia and other regions. Strategic partnerships and investments in research and development also play a crucial role in maintaining its competitive edge and expanding its product offerings. Furthermore, the company invests in marketing and brand development to enhance consumer recognition and loyalty, driving sales across its product categories.

Unicharm Financial Statement Overview

Summary
Unicharm demonstrates solid financial health with strong profitability and operational efficiency. Despite a slight revenue decline, the company maintains low leverage, a strong equity base, and robust cash flows, positioning it well for growth and resilience.
Income Statement
85
Very Positive
Unicharm's income statement demonstrates solid financial health with a consistent revenue growth trajectory. The TTM gross profit margin is 39.05%, and the net profit margin is 9.07%, indicating efficient management of costs and strong profitability. Revenue growth from 2024 to the TTM period was -0.89%, showing a slight decline, but the EBIT and EBITDA margins of 13.99% and 18.92% respectively, remain robust, showcasing operational efficiency.
Balance Sheet
80
Positive
The balance sheet reflects a stable financial position with a debt-to-equity ratio of 0.03, indicating low leverage. The return on equity stands at 11.75%, demonstrating effective use of equity to generate profits. The equity ratio is 63.74%, suggesting a strong capital structure with a majority of assets financed by equity. Overall, the company maintains a conservative financial structure with significant equity backing and low debt.
Cash Flow
88
Very Positive
Unicharm shows strong cash flow management with a free cash flow growth rate of -9.71% from 2024 to the TTM period. The operating cash flow to net income ratio is 1.39, indicating robust cash generation capabilities relative to net income. The free cash flow to net income ratio is 0.99, highlighting efficient conversion of profits into free cash flow. The company's cash flow position is strong, supporting its operational and strategic initiatives.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue988.98B941.79B898.02B782.72B727.48B
Gross Profit389.91B351.53B328.60B313.64B292.61B
EBITDA185.00B180.56B161.16B160.80B147.56B
Net Income81.84B86.05B67.61B72.75B52.34B
Balance Sheet
Total Assets1.24T1.13T1.05T987.65B893.41B
Cash, Cash Equivalents and Short-Term Investments261.05B253.77B307.60B307.30B297.11B
Total Debt26.85B28.57B27.02B38.31B33.18B
Total Liabilities366.26B345.38B340.61B352.22B330.76B
Stockholders Equity773.06B695.72B618.88B557.64B493.00B
Cash Flow
Free Cash Flow97.77B124.00B59.27B70.58B114.75B
Operating Cash Flow137.10B162.41B92.22B105.25B150.25B
Investing Cash Flow-73.84B-67.53B-7.14B-79.84B-41.70B
Financing Cash Flow-66.79B-67.01B-61.65B-45.18B-35.24B

Unicharm Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1024.00
Price Trends
50DMA
1068.12
Negative
100DMA
1139.77
Negative
200DMA
1217.33
Negative
Market Momentum
MACD
-7.39
Negative
RSI
42.17
Neutral
STOCH
57.82
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:8113, the sentiment is Negative. The current price of 1024 is below the 20-day moving average (MA) of 1030.05, below the 50-day MA of 1068.12, and below the 200-day MA of 1217.33, indicating a bearish trend. The MACD of -7.39 indicates Negative momentum. The RSI at 42.17 is Neutral, neither overbought nor oversold. The STOCH value of 57.82 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:8113.

Unicharm Peers Comparison

Overall Rating
UnderperformOutperform
Sector (53)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
65
Neutral
$1.89T21.5911.28%3.03%2.40%2.53%
53
Neutral
C$5.27B3.92-2.52%3.52%18.46%5.48%
$21.61B28.4910.99%2.18%
$2.68B34.205.72%1.85%
$2.74B19.657.58%2.14%
$3.40B14.5413.33%1.28%
75
Outperform
¥200.51B21.28
4.47%11.68%27.65%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:8113
Unicharm
1,024.00
-579.21
-36.13%
KAOCF
Kao
43.96
-1.42
-3.13%
KBYPF
Kobayashi Pharmaceutical Co
37.23
-0.56
-1.48%
LIOPF
Lion
10.16
0.89
9.60%
RPHCF
Rohto Pharmaceutical Co
14.72
-6.77
-31.50%
JP:7956
Pigeon Corporation
1,699.50
405.46
31.33%

Unicharm Corporate Events

Unicharm Reports Decline in H1 2025 Financial Performance Amid Stock Split
Aug 5, 2025

Unicharm Corporation reported a decline in its financial performance for the first half of 2025, with net sales decreasing by 4.8% compared to the previous year. Despite a slight increase in profit attributable to owners of the parent, the company’s core operating income and profit before tax saw significant decreases. The company also announced a 3-for-1 stock split effective January 1, 2025, impacting dividend payments and earnings per share calculations.

The most recent analyst rating on (JP:8113) stock is a Buy with a Yen5100.00 price target. To see the full list of analyst forecasts on Unicharm stock, see the JP:8113 Stock Forecast page.

Unicharm’s Treasury Share Acquisition Progress Update
Aug 1, 2025

Unicharm Corporation announced the progress of its treasury share acquisition, revealing that no shares were acquired in July 2025. The company had previously resolved to acquire up to 25 million shares by December 2025, but as of July 31, 2025, it had acquired over 10 million shares, valued at nearly 12 billion JPY. This move is part of Unicharm’s strategic financial management, potentially impacting shareholder value and market perception.

The most recent analyst rating on (JP:8113) stock is a Buy with a Yen1600.00 price target. To see the full list of analyst forecasts on Unicharm stock, see the JP:8113 Stock Forecast page.

Unicharm Reports Progress on Treasury Share Acquisition
Jul 1, 2025

Unicharm Corporation announced the progress of its treasury share acquisition, revealing that no shares were acquired in June 2025 despite a prior resolution to purchase up to 25 million shares. As of June 30, 2025, the company had acquired over 10 million shares, reflecting its ongoing strategy to manage its capital structure and enhance shareholder value.

The most recent analyst rating on (JP:8113) stock is a Buy with a Yen5100.00 price target. To see the full list of analyst forecasts on Unicharm stock, see the JP:8113 Stock Forecast page.

Unicharm Strengthens Philippine Subsidiary with Capital Increase
Jun 23, 2025

Unicharm Corporation has announced a capital increase for its subsidiary, UNICHARM (PHILIPPINES) CORP., which will result in the subsidiary becoming a specified subsidiary. This move is aimed at strengthening the financial foundation of the Philippine subsidiary, which has been experiencing financial challenges. Despite the capital increase, the impact on Unicharm’s consolidated financial results is expected to be negligible.

The most recent analyst rating on (JP:8113) stock is a Buy with a Yen5100.00 price target. To see the full list of analyst forecasts on Unicharm stock, see the JP:8113 Stock Forecast page.

Unicharm Expands into East Africa with New Joint Venture
Jun 18, 2025

Unicharm Corporation has announced the establishment of a joint venture, Sofy East Africa Limited, in collaboration with Toyota Tsusho Corporation and CFAO Kenya Limited. This venture aims to expand Unicharm’s business in Kenya and neighboring countries by enhancing local production and distribution capabilities. The initiative is expected to promote the spread of sanitary products in the region, support women’s social advancement, and address social issues, thereby strengthening Unicharm’s market position in East Africa.

The most recent analyst rating on (JP:8113) stock is a Buy with a Yen5100.00 price target. To see the full list of analyst forecasts on Unicharm stock, see the JP:8113 Stock Forecast page.

Unicharm Reports Progress on Treasury Share Acquisition
Jun 2, 2025

Unicharm Corporation announced the progress of its treasury share acquisition plan, revealing that no shares were acquired in May 2025. The company had previously set a resolution to acquire up to 25 million shares by December 2025, with a maximum budget of 22 billion JPY. As of the end of May, Unicharm had acquired over 10 million shares, valued at approximately 12 billion JPY, indicating a strategic move to optimize its capital structure.

The most recent analyst rating on (JP:8113) stock is a Buy with a Yen5100.00 price target. To see the full list of analyst forecasts on Unicharm stock, see the JP:8113 Stock Forecast page.

Unicharm Supports Education with Treasury Stock Disposal
May 9, 2025

Unicharm Corporation has resolved to dispose of 650,000 shares of its treasury stock through a third-party allotment to support SHINAGAWA JOSHI GAKUIN. This move, approved by the board and shareholders, aligns with the company’s efforts to contribute to the SDGs by supporting educational activities.

Unicharm Reports Mixed Financial Results for Q1 2025 Amid Stock Split
May 9, 2025

Unicharm Corporation reported a decrease in net sales and core operating income for the first quarter of 2025 compared to the previous year, with net sales down by 3.7% and core operating income down by 22.7%. Despite these declines, the company saw an increase in profit attributable to owners of the parent by 39.7%, indicating a potential shift in operational efficiency or cost management strategies. The company also executed a 3-for-1 stock split, impacting their earnings per share calculations, and adjusted their dividend forecasts accordingly.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 29, 2025